RUO — For Research Use Only | Not for Human Consumption

Articles & Insights

Research insights and compound updates from King Peptides.

P21 as a Cognitive Shield Against GLP-1 Brain Fog in the VA Trial

The VA is testing whether peptide P21 can prevent cognitive side effects from GLP-1 drugs like semaglutide. Early trial data show a 2.3-point MoCA

Aug 06, 2026· 4 min read

P21 as a Cognitive Shield Against GLP-1 Brain Fog in the VA Trial

Aug 06, 2026 · 4 min read

cognitive enhancement

P21 vs. Pinealon: Which Peptide Gains After FDA Panel Vote?

Aug 01, 2026 · 6 min read

cognitive enhancement

FDA Panel Vote on Peptide Access Could Reshape Nootropic Use

Jul 30, 2026 · 6 min read

P21 as a Neuroprotective Countermeasure for GLP-1 Cognitive Effects

Jul 25, 2026 · 5 min read

cognitive rehabilitation

P21 vs. Dihexa After Mild TBI: Neurogenic Potential Compared

Jul 22, 2026 · 6 min read